Resveratrol in management of bone and spinal cancers (Q50100670)

24 February 2018

title

Resveratrol in management of bone and spinal cancers (English)

1 reference

24 February 2018

author name string

Gang Chen

1

1 reference

24 February 2018

Hong Xia

2

1 reference

24 February 2018

Zhi-Guo Zhang

3

1 reference

24 February 2018

Hai-Liang Yu

4

1 reference

24 February 2018

publication date

20 October 2017

1 reference

24 February 2018

published in

Natural Product Research

1 reference

24 February 2018

page(s)

1-11

1 reference

24 February 2018

Potent antiproliferative effects of resveratrol on human osteosarcoma SJSA1 cells: Novel cellular mechanisms involving the ERKs/p53 cascade

cites work

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Therapeutic potential of resveratrol: the in vivo evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Induction of sirtuin-1 signaling by resveratrol induces human chondrosarcoma cell apoptosis and exhibits antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Determination of naturally occurring resveratrol analog trans-4,4'-dihydroxystilbene in rat plasma by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Antitumor effect of resveratrol on chondrosarcoma cells via phosphoinositide 3-kinase/AKT and p38 mitogen-activated protein kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Chondrosarcoma metastasis in the thyroid gland: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Resveratrol blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Biological effects of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

The resveratrol oligomers, cis- and trans-gnetin H, from Paeonia suffruticosa seeds inhibit the growth of several human cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

The clinical approach towards chondrosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Resveratrol induces MMP-9 and cell migration via the p38 kinase and PI-3K pathways in HT1080 human fibrosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Resveratrol attenuates matrix metalloproteinase-9 and -2-regulated differentiation of HTB94 chondrosarcoma cells through the p38 kinase and JNK pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Fibrosarcoma at the site of a metallic fixation of the tibia--a case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

mTOR signaling in osteosarcoma: Oncogenesis and therapeutic aspects (Review).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Diagnosis and treatment of Ewing's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Resveratrol inhibits phosphorylation within the signal transduction and activator of transcription 3 signaling pathway by activating sirtuin 1 in SW1353 chondrosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Regulatory effects of resveratrol on antioxidant enzymes: a mechanism of growth inhibition and apoptosis induction in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Ewing's sarcoma family of tumors: an overview from diagnosis to survivorship

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Resveratrol with antioxidant activity inhibits matrix metalloproteinase via modulation of SIRT1 in human fibrosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Resveratrol inhibits proliferation and promotes apoptosis of osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Role of osteopontin in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

JNK pathway in osteosarcoma: pathogenesis and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Pterostilbene exerts antitumor activity against human osteosarcoma cells by inhibiting the JAK2/STAT3 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Resveratrol and diallyl disulfide enhance curcumin-induced sarcoma cell apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element-binding protein and contributes to melanoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Anticancer Efficacy of Polyphenols and Their Combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

EWS/FLI mediates transcriptional repression via NKX2.2 during oncogenic transformation in Ewing's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Antinociceptive effect of resveratrol in carrageenan-evoked hyperalgesia in rats: prolonged effect related to COX-2 expression impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenström's macroglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Resveratrol induces senescence-like growth inhibition of U-2 OS cells associated with the instability of telomeric DNA and upregulation of BRCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Activation of Adenosine Monophosphate-activated Protein Kinase Suppresses Neuroinflammation and Ameliorates Bone Cancer Pain: Involvement of Inhibition on Mitogen-activated Protein Kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Reverse chemomodulatory effects of the SIRT1 activators resveratrol and SRT1720 in Ewing's sarcoma cells: resveratrol suppresses and SRT1720 enhances etoposide- and vincristine-induced anticancer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Forkhead proteins are critical for bone morphogenetic protein-2 regulation and anti-tumor activity of resveratrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Margin status and multimodal therapy in infantile fibrosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Resveratrol abrogates the effects of hypoxia on cell proliferation, invasion and EMT in osteosarcoma cells through downregulation of the HIF-1α protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Current treatment for Ewing's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Wnt/β-catenin pathway in bone cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Resveratrol as a pan-HDAC inhibitor alters the acetylation status of histone [corrected] proteins in human-derived hepatoblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

In vitro assays in natural products research - a matter of concentration and relevance to in vivo administration using resveratrol, α-mangostin/γ-mangostin and xanthohumol as examples

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Primary sclerosing epithelioid fibrosarcoma of bone: analysis of a series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Combined effect of 17β-estradiol and resveratrol against apoptosis induced by interleukin-1β in rat nucleus pulposus cells via PI3K/Akt/caspase-3 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Isorhapontigenin, a bioavailable dietary polyphenol, suppresses airway epithelial cell inflammation through a corticosteroid-independent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

Resveratrol inhibits canonical Wnt signaling in human MG-63 osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1389936

10.1080/14786419.2017.1389936

21 January 2018

Identifiers

DOI

1 reference

24 February 2018

1 reference

24 February 2018